Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BELIMUMAB vs BELZUTIFAN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BELIMUMAB vs BELZUTIFAN: Safety Overview

Metric BELIMUMAB BELZUTIFAN
Total FAERS Reports 26,773 1,021
Deaths Reported 788 82
Death Rate 2.9% 8.0%
Hospitalizations 3,771 550
Average Patient Age 47.2 yrs 60.2 yrs
% Female Patients 93.3% 41.6%
FDA Approval Date N/A Aug 13, 2021
Manufacturer GlaxoSmithKline LLC Merck Sharp & Dohme LLC
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription